2023 - Research.com Medicine in Lebanon Leader Award
Member of the Association of American Physicians
Mohamed H. Sayegh mainly investigates Immunology, Transplantation, T cell, Immune tolerance and Immune system. His work deals with themes such as Cytotoxic T cell and Blockade, which intersect with Immunology. His study in Cytotoxic T cell is interdisciplinary in nature, drawing from both Proinflammatory cytokine, Haematopoiesis, CD8 and Cytokine.
Within one scientific family, he focuses on topics pertaining to Programmed Cell Death 1 Ligand 2 Protein under Blockade, and may sometimes address concerns connected to Insulitis and Nod. His research investigates the connection between Transplantation and topics such as In vivo that intersect with issues in CD40. His T cell research integrates issues from Experimental autoimmune encephalomyelitis, B7-H1 Antigen, Macrophage and Immunotherapy.
The scientist’s investigation covers issues in Immunology, Transplantation, T cell, Immune system and Cell biology. Mohamed H. Sayegh focuses mostly in the field of Immunology, narrowing it down to matters related to Blockade and, in some cases, CD154. His Transplantation study deals with In vivo intersecting with In vitro.
Mohamed H. Sayegh works mostly in the field of T cell, limiting it down to topics relating to Cytotoxic T cell and, in certain cases, CD8, as a part of the same area of interest. His study ties his expertise on Immunotherapy together with the subject of Immune tolerance. His Internal medicine study frequently intersects with other fields, such as Endocrinology.
His scientific interests lie mostly in Immunology, Transplantation, T cell, Internal medicine and Immune system. The Immunology study which covers Cytotoxic T cell that intersects with Cancer research. The study incorporates disciplines such as Receptor, Immunosuppression and Cell biology, Effector in addition to Transplantation.
His research integrates issues of Molecular biology, Blockade, Immune tolerance and Alloimmunity in his study of T cell. His studies deal with areas such as Endocrinology and Cardiology as well as Internal medicine. The concepts of his Immune system study are interwoven with issues in Proinflammatory cytokine, Mesenchymal stem cell and Cytokine.
His primary areas of investigation include Immunology, Transplantation, T cell, Blockade and Cell biology. His Immunology research includes elements of Signal transduction, Mesenchymal stem cell and Heart transplantation. His study in Transplantation is interdisciplinary in nature, drawing from both Immunosuppression, Tolerance induction, Haematopoiesis and Islet.
Mohamed H. Sayegh usually deals with T cell and limits it to topics linked to Immune tolerance and Regulatory B cells, FOXP3 and IL-2 receptor. His Blockade study combines topics from a wide range of disciplines, such as Interleukin 17 and In vivo. His study looks at the relationship between Cell biology and fields such as Antigen, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Elisabeth M Zeisberg;Oleg Tarnavski;Michael Zeisberg;Adam L Dorfman.
Nature Medicine (2007)
Identification of cells initiating human melanomas
Tobias Schatton;George F. Murphy;Natasha Y. Frank;Kazuhiro Yamaura.
Tissue expression of PD-L1 mediates peripheral T cell tolerance
Mary E. Keir;Spencer C. Liang;Indira Guleria;Yvette E. Latchman.
Journal of Experimental Medicine (2006)
Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens
H. L. Weiner;A. Friedman;A. Miller;S. J. Khoury.
Annual Review of Immunology (1994)
Delayed graft function in kidney transplantation.
Norberto Perico;Dario Cattaneo;Mohamed H Sayegh;Giuseppe Remuzzi.
The Lancet (2004)
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.
Mohammed Javeed I. Ansari;Alan D. Salama;Alan D. Salama;Tanuja Chitnis;Tanuja Chitnis;R. Neal Smith.
Journal of Experimental Medicine (2003)
The Role of T-Cell Costimulatory Activation Pathways in Transplant Rejection
Mohamed H. Sayegh;Laurence A. Turka.
The New England Journal of Medicine (1998)
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.
Natasha Y. Frank;Armen Margaryan;Ying Huang;Tobias Schatton.
Cancer Research (2005)
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.
Andrew D. Wells;Xian Chang Li;Yongsheng Li;Matthew C. Walsh.
Nature Medicine (1999)
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
Mohamed H. Sayegh;Enver Akalin;Wayne W. Hancock;Mary E. Russell.
Journal of Experimental Medicine (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: